New York-based Jones, founded by Hilary Dubin and Caroline Vasquez Huber, raised a $10 million Series A round led by Foundry, valuing the nicotine lozenge startup at around $45 million. Jones aims to modernize nicotine replacement therapy with a stylish, judgment-free approach, offering lozenges alongside an app that supports users through cognitive behavioral therapy. The company, which generated $5 million in revenue last year, plans to use the funding to develop new products, expand its team, and grow its market presence. INVESTORS: Foundry, Founder Collective, Next View & Good Friends ROUND: Series A AMOUNT: $10,000,000 VALUATION: $45,000,000
Download the medial app to read full posts, comements and news.